BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 26263710)

  • 1. [Organized breast cancer screening].
    Rouëssé J; Sancho-Garnier H;
    Bull Acad Natl Med; 2014 Feb; 198(2):369-86. PubMed ID: 26263710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Organized colorectal cancer screening].
    Rouëssé J; Sancho-Garnier H;
    Bull Acad Natl Med; 2014 Feb; 198(2):387-99. PubMed ID: 26263711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difficulties in implementing an organized screening program for breast cancer in Brazil with emphasis on diagnostic methods.
    Silva TB; Mauad EC; Carvalho AL; Jacobs LA; Shulman LN
    Rural Remote Health; 2013; 13(2):2321. PubMed ID: 23597169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Organized or individual breast cancer screening: what motivates women?].
    Kalecinski J; Régnier-Denois V; Ouédraogo S; Dabakuyo-Yonli TS; Dumas A; Arveux P; Chauvin F
    Sante Publique; 2015; 27(2):213-20. PubMed ID: 26414035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding barriers to organized breast cancer screening in France: women's perceptions, attitudes, and knowledge.
    Ferrat E; Le Breton J; Djassibel M; Veerabudun K; Brixi Z; Attali C; Renard V
    Fam Pract; 2013 Aug; 30(4):445-51. PubMed ID: 23478254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420).
    French DP; Astley S; Brentnall AR; Cuzick J; Dobrashian R; Duffy SW; Gorman LS; Harkness EF; Harrison F; Harvie M; Howell A; Jerrison A; Machin M; Maxwell AJ; McWilliams L; Payne K; Qureshi N; Ruane H; Sampson S; Stavrinos P; Thorpe E; Ulph F; van Staa T; Woof V; Evans DG
    BMC Cancer; 2020 Jun; 20(1):570. PubMed ID: 32552763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer screening in women aged 50-74 years: is there room for improvement?
    Morère JF; Pivot X; Viguier J; Blay JY; Calazel-Benque A; Coscas Y; Roussel C; Eisinger F
    Eur J Cancer Prev; 2011 Jan; 20 Suppl 1():S8-S12. PubMed ID: 21245683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening for breast cancer: worries about its effectiveness].
    Autier P
    Rev Prat; 2013 Dec; 63(10):1369-77. PubMed ID: 24579331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of mammography screening for breast cancer in a low socioeconomic group of Iranian women.
    Barfar E; Rashidian A; Hosseini H; Nosratnejad S; Barooti E; Zendehdel K
    Arch Iran Med; 2014 Apr; 17(4):241-5. PubMed ID: 24724599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seventeen-years overview of breast cancer inside and outside screening in Denmark.
    Domingo L; Jacobsen KK; von Euler-Chelpin M; Vejborg I; Schwartz W; Sala M; Lynge E
    Acta Oncol; 2013 Jan; 52(1):48-56. PubMed ID: 22943386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation.
    Nelson HD; Pappas M; Cantor A; Griffin J; Daeges M; Humphrey L
    Ann Intern Med; 2016 Feb; 164(4):256-67. PubMed ID: 26756737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of radiation-induced breast cancers due to biennial mammographic screening in women aged 50-69 years is minimal.
    Hauge IH; Pedersen K; Olerud HM; Hole EO; Hofvind S
    Acta Radiol; 2014 Dec; 55(10):1174-9. PubMed ID: 24311702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is “mobile mammography” a Relevant Method in France?].
    Vallée A
    Sante Publique; 2016 Nov; 28(5):599-602. PubMed ID: 28155735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.
    US Preventive Services Task Force
    Ann Intern Med; 2009 Nov; 151(10):716-26, W-236. PubMed ID: 19920272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Using medical imaging for a comprehensive breast cancer screening program].
    Dilhuydy MH
    Bull Cancer; 2009 Nov; 96(11):1071-86. PubMed ID: 19887333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [French screening program of breast cancer. Results from 5 districts (1989-1994)].
    Séradour B; Allemand H; Schaffer P
    Bull Cancer; 1997 Aug; 84(8):822-8. PubMed ID: 9339188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience in the implementation of screening program for early detection of breast cancer in the Khanty-Mansi Autonomous Region-Yugra].
    Zakharova NA
    Vopr Onkol; 2013; 59(3):382-5. PubMed ID: 23909042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Program-specific cost-effectiveness analysis: breast cancer screening policies for a safety-net program.
    Melnikow J; Tancredi DJ; Yang Z; Ritley D; Jiang Y; Slee C; Popova S; Rylett P; Knutson K; Smalley S
    Value Health; 2013; 16(6):932-41. PubMed ID: 24041343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.